Abstract:Background: Compelling evidence suggests that SIRT1, NAD(+)-dependent class III protein deacetylase, plays an important role in the prevention and treatment of atherosclerosis by counteracting inflammation. Cluster of differentiation 40 (CD40), as a pro-inflammatory cytokine, has been shown to participate in the pathophysiology of atherosclerosis. The relationship between SIRT1 and CD40, however, remained elusive. The present study was thus designed to explore the potential effect of SIRT1 on CD40 expression induced by tumor necrosis factor-alpha (TNF-alpha) and to disclose the underlying mechanism in CRL-1730 endothelial cells. Methods: mRNA and protein expressions were identified by quantitative real-time PCR and Western blot respectively. Subcellular localization of SIRT1 was detected by immunofluorescence analysis. SIRT1 small-interfering RNA (siRNA) was carried out for mechanism study. Results: TNF-alpha reduced SIRT1 expression and induced CD40 expression in CRL-1730 endothelial cells in a time- and concentration- dependent manner. Pretreatment with resveratrol (a potent SIRT1 activator) inhibited TNF-alpha-induced CD40 expression, while pretreatment with nicotinamide (class beta HDACs inhibitor nicotinamide) or sirtinol (a known SIRT1 inhibitor), especially SIRT1 siRNA significantly augmented TNF-alpha-induced CD40 expression. The frther sudy idicated that PDTC (NF-kappa B inhibitor) pretreatment attenuated TNF-alpha-induced CD40 expression, and SIRT1 siRNA significantly augmented TNF-alpha-induced acetylated-NF-kappa B p65 (Lys310) expression. Conclusion: The present study provides the direct evidence that SIRT1 can inhibit TNF-alpha-induced CD40 expression in CRL-1730 endothelial cells by deacetylating the RelA/p65 subunit of NF-kappa B at lysine 310, which provides new insights into understanding of the anti-inflammatory and anti-athroscerotic actions of SIRT1. Copyright (C) 2012 S. Karger AG, Basel

Sirtuin 1 inhibits lipopolysaccharide-induced inflammation in chronic myelogenous leukemia k562 cells through interacting with the Toll-like receptor 4-nuclear factor κ B-reactive oxygen species signaling axis

Non-Lyn Src Family Kinases Activate SIRPα-SHP-1 to Inhibit PI3K-Akt2 and Dampen Proinflammatory Macrophage Polarization

Myeloid Deletion of SIRT1 Induces Inflammatory Signaling in Response to Environmental Stress.

SIRT1 Regulates Lipopolysaccharide-Induced CD40 Expression in Renal Medullary Collecting Duct Cells by Suppressing the TLR4-NF-κB Signaling Pathway.

SIRT1 Regulates the Phosphorylation and Degradation of P27 by Deacetylating CDK2 to Promote T-cell Acute Lymphoblastic Leukemia Progression.

Vitamin C Inhibits Lipopolysaccharide-Induced Hyperinflammatory State of Chronic Myeloid Leukemia Cells through Purinergic Signaling and Autophagy

Sirtuin 1 activator alleviated lethal inflammatory injury via promotion of autophagic degradation of pyruvate kinase M2

Sirtuin 1 (sirt1) Overexpression in BaF3 Cells Contributes to Cell Proliferation Promotion, Apoptosis Resistance and Pro-Inflammatory Cytokine Production

SIRT1 Inhibits Inflammatory Response Partly Through Regulation of NLRP3 Inflammasome in Vascular Endothelial Cells.

Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib.

SIRT1 regulates CD40 expression induced by TNF-α via NF-ĸB pathway in endothelial cells.

SIRT1 Inhibition Impairs Non-Homologous End Joining DNA Damage Repair by Increasing Ku70 Acetylation in Chronic Myeloid Leukemia Cells

SIRT1 slows the progression of lupus nephritis by regulating the NLRP3 inflammasome through ROS/TRPM2/Ca2+ channel

Chronic Inflammation Deters Natural Killer Cell Fitness and Cytotoxicity in Myeloid Leukemia

Inhibition of SIRT1 by Microrna-9, the Key Point in Process of LPS-induced Severe Inflammation

MCPIP1 Alleviated Lipopolysaccharide‐induced Liver Injury by Regulating SIRT1 Via Modulation of Microrna‐9

Sensitizing leukemia stem cells to NF-κB inhibitor treatment in vivo by inactivation of both TNF and IL-1 signaling.

SIRT1 regulates inflammation response of macrophages in sepsis mediated by long noncoding RNA.

3147 – SPHINGOSINE-1-PHOSPHATE RECEPTOR 3 SIGNALING DEPLETES LEUKEMIA STEM CELLS BY INDUCING DIFFERENTIATION

Activation of Sirt1 by Resveratrol Inhibits TNF-α Induced Inflammation in Fibroblasts

Role of SIRT1 in Regulation of LPS- or Two Ethanol Metabolites-Induced TNF-alpha Production in Cultured Macrophage Cell Lines.